Precipio Depreciation & Amortization 2011-2026 | PRPO

Annual Depreciation & Amortization Precipio

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
1.24 M	1.2 M	1.22 M	1.22 M	1.13 M	1.09 M	1.12 M	1.26 M	743 K	112 K	489 K	569 K	2.75 M	2.28 M	2.1 M	708 K	852 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.75 M	112 K	1.18 M

Quarterly Depreciation & Amortization Precipio

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
281 K	-	-	324 K	-	-	-	304 K	-	-	-	310 K	-	910 K	604 K	302 K	-	835 K	549 K	268 K	-	829 K	564 K	281 K	-	838 K	560 K	277 K	-	972 K	680 K	352 K	-	395 K	48 K	24 K	-	99 K	55 K	83 K	-	343 K	558 K	41 K	-	589 K	488 K	493 K	-	671 K	687 K	744 K	-	495 K	532 K	513 K	-	481 K	499 K	494 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
972 K	24 K	459 K

Depreciation & Amortization of other stocks in the Diagnostics research industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	1.27 M	-	-8.98 %	$ 14.8 K	USA
Heska Corporation HSKA	14 M	-	-	$ 1.31 B	USA
Quest Diagnostics Incorporated DGX	570 M	$ 203.78	-0.37 %	$ 22.6 B	USA
Celcuity CELC	167 K	$ 88.24	-4.7 %	$ 4.13 B	USA
Akumin AKU	98.2 M	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	1.11 M	$ 4.88	8.44 %	$ 6.49 M	USA
Fulgent Genetics FLGT	24.1 M	$ 18.93	2.32 %	$ 583 M	USA
Castle Biosciences CSTL	40.8 M	$ 21.08	-	$ 611 M	USA
Aspira Women's Health AWH	112 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	1.4 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	1.66 M	-	-13.05 %	$ 7.29 M	USA
ICON Public Limited Company ICLR	383 M	$ 144.59	-4.76 %	$ 11.3 B	Irlanda
Illumina ILMN	270 M	$ 162.47	1.52 %	$ 25.2 B	USA
Guardant Health GH	39.7 M	$ 130.7	0.45 %	$ 16.4 B	USA
CareDx, Inc CDNA	15 M	$ 23.46	3.12 %	$ 1.25 B	USA
Chembio Diagnostics CEMI	2.55 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	161 K	-	-	$ 9.42 M	Israel
Interpace Biosciences IDXG	425 K	$ 1.76	1.32 %	$ 7.79 M	USA
HTG Molecular Diagnostics HTGM	587 K	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	43.3 M	-	-	$ 399 M	China
DermTech DMTK	200 K	-	-11.32 %	$ 2.94 M	USA
Lantheus Holdings LNTH	70.1 M	$ 100.24	0.26 %	$ 6.77 B	USA
Charles River Laboratories International CRL	403 M	$ 186.29	-1.88 %	$ 9.23 B	USA
Pacific Biosciences of California PACB	13 M	$ 1.37	-	$ 411 M	USA
Medpace Holdings MEDP	27.2 M	$ 465.73	-0.23 %	$ 13.4 B	USA
Exact Sciences Corporation EXAS	125 M	-	-	$ 19.8 B	USA
Mettler-Toledo International MTD	51.1 M	$ 1 133.03	-2.58 %	$ 23.4 B	Schweiz
NeoGenomics NEO	36.1 M	$ 11.28	-1.4 %	$ 1.44 B	USA
Myriad Genetics MYGN	53.7 M	$ 4.43	-2.42 %	$ 410 M	USA
National Research Corporation NRC	7.62 M	$ 21.28	7.75 %	$ 476 M	USA
Natera NTRA	41.8 M	$ 216.5	-2.84 %	$ 29.6 B	USA
Personalis PSNL	10 M	$ 9.61	-1.44 %	$ 858 M	USA
Koninklijke Philips N.V. PHG	1.12 B	$ 25.67	-3.13 %	$ 24.3 B	Niderland
Senseonics Holdings SENS	1.51 M	$ 7.3	-1.75 %	$ 305 M	USA
QIAGEN N.V. QGEN	194 M	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	2.02 M	-	-	$ 2.69 B	USA
Biomerica BMRA	87 K	$ 2.02	-1.51 %	$ 4.64 M	USA
Twist Bioscience Corporation TWST	24.9 M	$ 67.77	-3.27 %	$ 4.05 B	USA
Laboratory Corporation of America Holdings LH	681 M	$ 268.63	-0.96 %	$ 22.4 B	USA
Thermo Fisher Scientific TMO	1.05 B	$ 482.04	-2.43 %	$ 182 B	USA
Motus GI Holdings MOTS	451 K	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	119 M	$ 9.17	-1.29 %	$ 1.99 B	USA
Invitae Corporation NVTA	142 M	-	-	$ 21.2 M	USA